Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Botanix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Health & Biotech
ScoPo’s Powerplays: Health stocks tumble but half-price sale presents buying opportunities
Health & Biotech
Weed Week: Jim Belushi headlines cannabis expo and the first legal seedbank established in Denmark
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Stockhead TV
Resolving Acne: Dermatology innovations in biotech
Explainers
ASX Cannabis Stocks Guide 2021: Here’s everything you need to know
News
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Botanix soars after pot-up-nose study success
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
Health & Biotech
Botanix collab with UQ confirms antimicrobial potential of CBD
Health & Biotech
Superbugs will kill 22,000 Australians annually by 2040; but these stocks are trying to stop that
News
September Winners Column: Battery metals sentiment has come roaring back
Health & Biotech
Check up: dorsaVi leads ASX health gainers with 60pc rise
Health & Biotech
Weed Week: US cannabis companies wanna take it to the bank
Health & Biotech
